Re: New York Times: Free Drug Samples? Bad Idea, Some Say
- From: "Pete" <pete@xxxxxxxxxx>
- Date: Wed, 2 May 2007 14:34:53 -0400
Just look at it this way - Nexium is the left side of the optical
isomer for Prilosec. Why do you think that is. It is very simple -
it is so the Pharma could start up another long term patent for
something they already invented. It's all about patent laws and
making money. I think the patient is just a pawn being moved
around. And of course, we don't want to even mention the subject of
curing a disease, versus keeping it at bay - not good for big Pharma - a
subject constantly discussed in
this, and many other ng's :-) .
Yet, if a cure for a disease were available, some drug company would
start to make it. They care about their profit, not other pharma
companies' profit.
Jeff
That's the whole point Jeff. If they find a cure, they will lose their
continuing profit which they get from all the maintenance type drugs that
people take long term. That is where they get most of their money from. It
is a basic concept of the dog eat dog capitalistic world we live in.
I didn't want to get into a discussion on this last part of my post, and I
just tossed it in as kind of an aside for some levity. But I don't
understand your logic on this, and doubt whether very many people would
agree with you. I see no incentive for big Pharma to try to cure a disease
and get a one time profit (so to speak) - it's not logical, even though it
is rather inhumane. Like I said, this has been discussed at length in many
ng's for years, as you are well aware of.
Pete
.
- Follow-Ups:
- Re: New York Times: Free Drug Samples? Bad Idea, Some Say
- From: Kurt Ullman
- Re: New York Times: Free Drug Samples? Bad Idea, Some Say
- References:
- Prev by Date: Retinal Transplant
- Next by Date: Re: New York Times: Free Drug Samples? Bad Idea, Some Say
- Previous by thread: Re: New York Times: Free Drug Samples? Bad Idea, Some Say
- Next by thread: Re: New York Times: Free Drug Samples? Bad Idea, Some Say
- Index(es):
Relevant Pages
|